These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 11242692

  • 1. Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients.
    Prabhu R, John GT, Shankar V, Thomas PP, Abi Abraham M, Jeyaseelan L, Jacob CK.
    Natl Med J India; 2001; 14(1):18-21. PubMed ID: 11242692
    [Abstract] [Full Text] [Related]

  • 2. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 4. The UNOS renal transplant registry.
    Cecka JM.
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [Abstract] [Full Text] [Related]

  • 5. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [Abstract] [Full Text] [Related]

  • 6. Explainable variation in renal transplant outcomes: a comparison of standard and expanded criteria donors.
    Gjertson DW.
    Clin Transpl; 2004; ():303-14. PubMed ID: 16704159
    [Abstract] [Full Text] [Related]

  • 7. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC.
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [Abstract] [Full Text] [Related]

  • 8. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 9. Ischemia times and donor serum creatinine in relation to renal graft failure.
    Roodnat JI, Mulder PG, Van Riemsdijk IC, IJzermans JN, van Gelder T, Weimar W.
    Transplantation; 2003 Mar 27; 75(6):799-804. PubMed ID: 12660505
    [Abstract] [Full Text] [Related]

  • 10. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Mar 27; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 11. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK.
    Nephrol Dial Transplant; 2005 Jan 27; 20(1):167-75. PubMed ID: 15546892
    [Abstract] [Full Text] [Related]

  • 12. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ, Kwak JY, Kang CM.
    Transplant Proc; 2005 Mar 27; 37(2):726-8. PubMed ID: 15848514
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for prolonged hospitalization after kidney transplants.
    Matas AJ, Gillingham KJ, Elick BA, Dunn DL, Gruessner RW, Payne WD, Sutherland DE, Najarian JS.
    Clin Transplant; 1997 Aug 27; 11(4):259-64. PubMed ID: 9267712
    [Abstract] [Full Text] [Related]

  • 14. Renal allograft failure after simultaneous pancreas-kidney transplantation: univariate and multivariate analyses of donor and recipient risk factors.
    Douzdjian V, Rice JC, Carson RW, Gugliuzza KG, Fish JC.
    Clin Transplant; 1996 Jun 27; 10(3):271-7. PubMed ID: 8826665
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May 27; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 16. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M, Tarantino A, Berardinelli L, Finazzi S, Montagnino G, Rossini G, Scalamogna M, Cesana B, Ponticelli C.
    G Ital Nefrol; 2002 May 27; 19(1):49-54. PubMed ID: 12165946
    [Abstract] [Full Text] [Related]

  • 17. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
    El-Husseini AA, Foda MA, Shokeir AA, Shehab El-Din AB, Sobh MA, Ghoneim MA.
    Pediatr Transplant; 2005 Dec 27; 9(6):763-9. PubMed ID: 16269048
    [Abstract] [Full Text] [Related]

  • 18. Grandparent donors in a living related renal transplant program.
    Nyberg SL, Manivel JC, Cook ME, Gillingham KJ, Matas AJ, Najarian JS.
    Clin Transplant; 1997 Oct 27; 11(5 Pt 1):349-53. PubMed ID: 9361922
    [Abstract] [Full Text] [Related]

  • 19. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB, Hothersall E, Preston J, Brown AM, Hawley CM, Wall D, Griffin AD, Isbel NM, Nicol DL, Johnson DW.
    Transplantation; 2003 Nov 27; 76(10):1452-7. PubMed ID: 14657685
    [Abstract] [Full Text] [Related]

  • 20. The older living kidney donor: Part of the solution to the organ shortage.
    Gill JS, Gill J, Rose C, Zalunardo N, Landsberg D.
    Transplantation; 2006 Dec 27; 82(12):1662-6. PubMed ID: 17198256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.